Latigo Biotherapeutics, Inc.

Latigo Biotherapeutics, Inc.

Biotechnology Research

Thousand Oaks, CA 5,650 followers

Uniquely poised to disrupt pain therapy.

About us

Latigo Biotherapeutics Inc., headquartered in Thousand Oaks, CA, is a privately held clinical-stage biotechnology company developing best-in-class non-opioid pain medicines that target the fundamental mechanism of pain transduction. The company’s proprietary, in-house technology generates novel drugs against targets validated by human genetics using the most advanced artificial intelligence, machine learning, structure-based, and knowledge-based design techniques to optimize potency and selectivity. The company is backed by top-tier investors, including Westlake Village BioPartners, 5AM Ventures, Foresite Capital, and Corner Ventures.

Website
www.latigobio.com
Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Thousand Oaks, CA
Type
Privately Held

Locations

Employees at Latigo Biotherapeutics, Inc.

Updates

Similar pages

Browse jobs

Funding